Received Feb 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
has not received the second dose of Shingrix vaccine; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose during April 2024 in left arm). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: has not received the second dose of Shingrix vaccine). The outcome of the incomplete course of vaccination was unknown. Additional Information: GSK Receipt Date: 07-FEB-2025 The patient received the 1st dose of Shingrix at a local pharmacy,the lot and expiry were unknown. The patient reports he has not received the second dose of Shingrix vaccine, which led incomplete course of vaccination. It was unknown why the patient did not get the vaccine between 2 to 6 months after the 1st dose. The reporter did not consent to follow-up.